Skip to content
brinzolamide

Structure via PubChem · Public domain (PubChem)

EntityQ411517· pop 20· linked from 65 articles

brinzolamide

Sign in to save

Brinzolamide (trade name Azopt) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Chemical data

Formula
C12H21N3O5S3
Molecular weight
383.5 g/mol
IUPAC name
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
SMILES
CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
InChIKey
HCRKCZRJWPKOAR-JTQLQIEISA-N
XLogP
-0.3
Polar surface area
164 Ų
H-bond donors
2
H-bond acceptors
9
Formal charge
0

via PubChem

Wikidata facts

Mass
383.064
Show 6 more facts
defined daily dose
0.2
chemical formula
C₁₂H₂₁N₃O₅S₃
World Health Organisation international non-proprietary name
brinzolamide
isomeric SMILES
CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
Commons category
Brinzolamide
canonical SMILES
CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
Sources (5)

via Wikidata · CC0

~4 min read

Article

16 sections
Contents
  • Chemistry
  • Indications
  • Pharmacodynamics
  • Pharmacokinetics
  • Absorption
  • Distribution
  • Metabolism
  • Excretion
  • Cautions
  • Side effects
  • Precautions
  • Combinations
  • With timolol
  • With brimonidine
  • References
  • Further reading

Brinzolamide (trade name Azopt) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Brinzolamide was approved as a generic medication in the United States in November 2020.

Connections

Categories